Matches in Nanopublications for { ?s ?p "[The residual tumor autophagy marker LC3B serves as a prognostic marker in local advanced breast cancer after neoadjuvant chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP951814.RAoDOma7zFF50mLkLNEZ9dj7V4jI2pd7rOgxtos6mLBT4130_assertion description "[The residual tumor autophagy marker LC3B serves as a prognostic marker in local advanced breast cancer after neoadjuvant chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP951814.RAoDOma7zFF50mLkLNEZ9dj7V4jI2pd7rOgxtos6mLBT4130_provenance.
- NP951830.RAkjT1hTK_-7eeyXqMzqnERVQe5KFTVxggnsAtTEx-t_Y130_assertion description "[The residual tumor autophagy marker LC3B serves as a prognostic marker in local advanced breast cancer after neoadjuvant chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP951830.RAkjT1hTK_-7eeyXqMzqnERVQe5KFTVxggnsAtTEx-t_Y130_provenance.
- assertion description "[The residual tumor autophagy marker LC3B serves as a prognostic marker in local advanced breast cancer after neoadjuvant chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The residual tumor autophagy marker LC3B serves as a prognostic marker in local advanced breast cancer after neoadjuvant chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1120899.RABn506Ep_jB7L40Fycuf5GQylJ47xnbrqZmQNYbypndc130_assertion description "[The residual tumor autophagy marker LC3B serves as a prognostic marker in local advanced breast cancer after neoadjuvant chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1120899.RABn506Ep_jB7L40Fycuf5GQylJ47xnbrqZmQNYbypndc130_provenance.
- NP1120903.RAuF5Gfw5zwJLQmQzGMRZfFZ5V9kL1zLd9NUhGzeQBLgg130_assertion description "[The residual tumor autophagy marker LC3B serves as a prognostic marker in local advanced breast cancer after neoadjuvant chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1120903.RAuF5Gfw5zwJLQmQzGMRZfFZ5V9kL1zLd9NUhGzeQBLgg130_provenance.